Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 17366456.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The European Surveillance of Antimicrobial Consumption (ESAC) project collects data on antibacterial use in Europe, applying the Anatomic Therapeutic Chemical classification system and defined daily dose methodology, as recommended by the World Health Organization. Comparable data for the United States have been collected from IMS Health. The IMS Health sales data, processed according to ESAC methodology, suggest that outpatient antibacterial use in the United States is high (only 3 of 27 European countries used more) and is mainly characterized by a shift towards newer antibiotics.
Medical subject headings
- Drug Prescriptions
- Drug Utilization
- Outpatients